{"id":771,"date":"2024-04-02T20:22:38","date_gmt":"2024-04-03T03:22:38","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?page_id=771"},"modified":"2026-04-02T14:15:18","modified_gmt":"2026-04-02T21:15:18","slug":"cbt-001","status":"publish","type":"page","link":"https:\/\/cloudbreakpharma.com\/zh\/pipeline\/cbt-001\/","title":{"rendered":"CBT-001"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"771\" class=\"elementor elementor-771\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f0b21f1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f0b21f1\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b30f889\" data-id=\"b30f889\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fc87f17 elementor-widget elementor-widget-heading\" data-id=\"fc87f17\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">CBT-001<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-89d9907 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"89d9907\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-eac25f5\" data-id=\"eac25f5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ef23022 elementor-widget elementor-widget-heading\" data-id=\"ef23022\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">A potential first-in-class treatment for patients with pterygium<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-090b662 elementor-widget elementor-widget-text-editor\" data-id=\"090b662\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"p1\" style=\"text-align: center;\"><span class=\"s1\" style=\"color: #ffffff;\">CBT-011 is currently in a Phase 3 clinical trial (NCT05456425) as a disease-modifying eyedrop therapy for pterygium.<\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-13bba45 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"13bba45\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-f530c01\" data-id=\"f530c01\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6f05c25 elementor-widget elementor-widget-heading\" data-id=\"6f05c25\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u7a81\u7834\u6027\u521b\u65b0<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9d4730f elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"9d4730f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"p1\"><span class=\"s1\">Our Core Product CBT-001 is a potential first-in-class drug therapy using a multi-kinase inhibitor targeting platelet-derived growth factor receptors (\u201cPDGFRs\u201d), fibroblast growth factor receptors (\u201cFGFRs\u201d), and vascular endothelial growth factor receptors (\u201cVEGFRs\u201d). This unique eye drop is being developed as a treatment for pterygium, including reducing the size of the lesion as well as common, bothersome symptoms.<\/span><\/p><p><span class=\"s1\">To our knowledge, there is currently no approved drug therapy for the treatment of pterygium globally, and the current existing treatment option for pterygium is surgical excision. If approved, CBT-001 is expected to be the first drug therapy globally for the treatment of pterygium and related bothersome symptoms, and to potentially reduce or postpone the need for surgical excision.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8248df6 elementor-widget elementor-widget-button\" data-id=\"8248df6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/cloudbreakpharma.com\/zh\/our-focus\/pterygium\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more about Pterygium<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-5c4a50e\" data-id=\"5c4a50e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8aba8bd elementor-widget elementor-widget-video\" data-id=\"8aba8bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;video_type&quot;:&quot;hosted&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-hosted-video elementor-wrapper elementor-open-inline\">\n\t\t\t\t\t<video class=\"elementor-video\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/cloudbreak_with_clinical_data-new-logo.mp4\" controls=\"\" preload=\"metadata\" controlslist=\"nodownload\"><\/video>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7a9d19a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7a9d19a\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6063760\" data-id=\"6063760\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fea6195 elementor-widget elementor-widget-heading\" data-id=\"fea6195\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u6709\u836f\u7269\u6548\u6027\u80fd\u4e0e\u5b89\u5168\u6027<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b0b1d3d elementor-widget elementor-widget-heading\" data-id=\"b0b1d3d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><p style=\"line-height: 107%;margin: 0pt 0in 8pt;direction: ltr\"><b><span style=\"color: var( --e-global-color-4862d202 );background-color: var( --e-global-color-3204c9d )\">2\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/span><sup style=\"color: var( --e-global-color-4862d202 );background-color: var( --e-global-color-3204c9d )\">7<\/sup><\/b><span style=\"color: var( --e-global-color-4862d202 );background-color: var( --e-global-color-3204c9d )\"><\/span><\/p><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-024262b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"024262b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-c9ce449\" data-id=\"c9ce449\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c3b6e87 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"c3b6e87\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"676\" height=\"380\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png\" class=\"attachment-large size-large wp-image-799\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png 676w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1-300x169.png 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1-18x10.png 18w\" sizes=\"(max-width: 676px) 100vw, 676px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-cba7ddd\" data-id=\"cba7ddd\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fd6801e elementor-widget elementor-widget-text-editor\" data-id=\"fd6801e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>2\u671f\u4e34\u5e8a\u8bd5\u9a8c<u><a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03049852\">NCT03049852<\/a><\/u>\u5206\u4e3a\u4e24\u4e2a\u9636\u6bb5\u3002 \u7b2c\u4e00\u9636\u6bb5\u5305\u62ec\u5bf9 24 \u540d\u60a3\u8005\u8fdb\u884c CBT-001 \u5242\u91cf\u9012\u589e\uff0c\u4ee5\u786e\u5b9a\u6700\u5927\u8010\u53d7\u5242\u91cf\u3002 \u7ed3\u679c\u8bc1\u660e\u4e86\u773c\u90e8\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u5168\u8eab\u836f\u7269\u66b4\u9732\u53ef\u5ffd\u7565\u4e0d\u8ba1\u3002 \u5728\u7b2c 2 \u9636\u6bb5\uff0c51 \u540d\u60a3\u8005\u63a5\u53d7\u4e86\u4e3a\u671f 4 \u5468\u7684 TID \u5468\u671f CBT-001 (n=25) \u6216\u8f7d\u4f53 (n=23) \u7ed9\u836f\u6cbb\u7597\uff0c\u5e76\u968f\u8bbf\u81f3\u7b2c 24 \u5468\u3002\u5230\u7b2c 4 \u5468\uff0c\u7528\u836f\u7ec4\u7684\u5e73\u5747\u8840\u7ba1\u5206\u5e03\u8bc4\u5206\u6bd4\u5bf9\u7167\u7ec4\u663e\u8457\u4e0b\u964d, \u5e76\u4e00\u76f4\u6301\u7eed\u5230\u7b2c 16 \u5468\u3002\u6b64\u5916\uff0c\u5728\u7b2c 4 \u5468\u89c2\u5bdf\u5230\u75c5\u7076\u957f\u5ea6\u7684\u5e73\u5747\u53d8\u5316\u6bd4\u5bf9\u7167\u7ec4\u660e\u663e\u51cf\u5c11\uff0c\u5e76\u4e00\u76f4\u6301\u7eed\u5230\u7b2c 8\u5468\u3002<sup>7<\/sup><\/p>\n<p>CBT-001 \u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0cCBT-001 \u7ec4\u4e2d\u5e38\u89c1\u62a5\u544a\u7684\u5927\u591a\u6570\u4e0d\u826f\u4e8b\u4ef6\u662f\u773c\u90e8\u4e0d\u826f\u4e8b\u4ef6\uff0c\u4e25\u91cd\u7a0b\u5ea6\u8f83\u8f7b\uff0c\u5e76\u5728\u6cbb\u7597\u540e\u5f97\u5230\u7f13\u89e3\u3002 \u6ca1\u6709\u60a3\u8005\u56e0\u4e0d\u826f\u4e8b\u4ef6\u800c\u505c\u6b62 CBT-001 \u6cbb\u7597\u3002<sup>7<\/sup><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-9efc908 elementor-widget elementor-widget-heading\" data-id=\"9efc908\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><p style=\"line-height:150%\"><b>3\u671f\u4e34\u5e8a\u8bd5\u9a8c<sup>8<\/sup><\/b><span style=\"color: var( --e-global-color-4862d202 );background-color: var( --e-global-color-3204c9d )\"><\/span><\/p><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e804b91 elementor-widget elementor-widget-image\" data-id=\"e804b91\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"223\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-1024x286.png\" class=\"attachment-large size-large wp-image-795\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-1024x286.png 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-300x84.png 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-768x214.png 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-1536x429.png 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-2048x572.png 2048w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/03\/Phase3_trial_graphic-002-18x5.png 18w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7d5c81a elementor-widget elementor-widget-text-editor\" data-id=\"7d5c81a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>3\u671f\u4e34\u5e8a\u8bd5\u9a8c <span style=\"font-size: 12pt; font-family: Arial; color: black;\">(<\/span><u><span style=\"font-size: 12pt; font-family: Arial; color: #0563c1;\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05456425\">NCT05456425<\/a><\/span><\/u><span style=\"font-size: 12pt; font-family: Arial; color: black;\">)<\/span> is designed to evaluate the efficacy and safety of CBT-001 in patients with pterygium.<sup>8<\/sup><\/p><p><strong>\u65b9\u6848\u6807\u9898\uff1a<\/strong>\u5bf9\u7ffc\u72b6\u80ec\u8089\u60a3\u8005\u8fdb\u884c\u591a\u4e2d\u5fc3\u3001\u53cc\u76f2\u3001\u968f\u673a\u3001\u8f7d\u4f53\u5bf9\u7167 12 \u4e2a\u6708\u5e73\u884c\u6bd4\u8f83 0.1% \u548c 0.2% CBT-001 \u4e0e\u8f7d\u4f53\uff08\u6bcf\u5929\u7ed9\u836f\u4e24\u6b21\uff09\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027<\/p><p><strong>\u7814\u7a76\u76ee\u7684\uff1a<\/strong>\u8bc4\u4f30 0.1% \u548c 0.2% CBT-001 \u4e73\u5242\u6bcf\u5929\u4e24\u6b21\u7ed9\u836f\uff0c\u6301\u7eed 24 \u4e2a\u6708\uff0c\u4e0e\u8f7d\u4f53\u76f8\u6bd4\uff0c\u5728\u51cf\u5c11\u7ffc\u72b6\u80ec\u8089\u773c\u7ed3\u819c\u5145\u8840\u548c\u9884\u9632\u7ffc\u72b6\u80ec\u8089\u8fdb\u5c55\u65b9\u9762\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027<\/p><p><strong>\u76ee\u6807\u5165\u7ec4\uff1a<\/strong>600 \u540d\u60a3\u8005<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-f8022e9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f8022e9\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-03c4e5d\" data-id=\"03c4e5d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bf53709 elementor-widget elementor-widget-text-editor\" data-id=\"bf53709\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>\u4e3b\u8981\u7eb3\u5165\u6807\u51c6\uff1a<\/strong><\/p><ul style=\"margin-top: 0cm;\" type=\"disc\"><li><span lang=\"EN-US\">\u5e74\u9f84\u226512 \u5c81\u7684\u7537\u6027\u6216\u5973\u6027<\/span><\/li><li><span lang=\"EN-US\">\u89d2\u819c\u4e0a\u65b9\u7ffc\u72b6\u80ec\u8089\u75c5\u53d8\u957f\u5ea6\u22651.2\u6beb\u7c73 <\/span><\/li><li><span lang=\"EN-US\">\u22653\u7ea7\u7ed3\u819c\u5145\u8840<\/span><\/li><\/ul><div>\u00a0<\/div><div>\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-cae5b39\" data-id=\"cae5b39\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7a84969 elementor-widget elementor-widget-text-editor\" data-id=\"7a84969\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"MsoNormal\"><strong>\u4e3b\u8981\u6392\u9664\u6807\u51c6\uff1a<\/strong><\/p><ul style=\"margin-top: 0cm;\" type=\"disc\"><li class=\"MsoNormal\"><span lang=\"EN-US\">\u8fc7\u53bb 6 \u4e2a\u6708\u5185\u8fdb\u884c\u8fc7\u7ffc\u72b6\u80ec\u8089\u5207\u9664\u624b\u672f<\/span><\/li><li class=\"MsoNormal\"><span lang=\"EN-US\">\u9884\u671f\u5728\u7814\u7a76\u5165\u7ec4\u4e00\u5e74\u5185\u8fdb\u884c\u7ffc\u72b6\u80ec\u8089\u624b\u672f <\/span><\/li><li class=\"MsoNormal\"><span lang=\"EN-US\">\u9664\u7ffc\u72b6\u80ec\u8089\u4ee5\u5916\u7684\u5177\u6709\u4e34\u5e8a\u610f\u4e49\u7684\u89d2\u819c\u5f02\u5e38<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-0ba653b elementor-widget elementor-widget-text-editor\" data-id=\"0ba653b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"x_MsoNormal\"><b data-olk-copy-source=\"MessageBody\">This Phase 3 clinical trial is fully enrolled with a data readout expected 3Q2026.\u00a0<\/b><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bdb28ec elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bdb28ec\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-78c2768\" data-id=\"78c2768\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-eac31d8 elementor-widget elementor-widget-text-editor\" data-id=\"eac31d8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"line-height: 107%; margin-top: 0pt; margin-bottom: 8pt; margin-left: 0in; direction: ltr; unicode-bidi: embed; word-break: normal;\"><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">BID, twice daily; DRC, data review committee; FGFR, fibroblast growth factor receptor; M, month; PDGFR, platelet-derived growth factor receptor; <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">PK, pharmacokinetics;<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">\u00a0<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">TID, three times daily; VEGFR, vascular endothelial growth factor receptor.<\/span><\/p><p style=\"line-height: 107%; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; direction: ltr; unicode-bidi: embed; word-break: normal;\"><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">1. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Shahraki<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> T, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Ther Adv <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Ophthalmol<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. 2021;13:25158414211020152. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">2. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Chu WK, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Eye (Lond)<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. 2020;34(6):1047-1050.<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> 3. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Wanzeler<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> ACV, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Clin <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Ophthalmol<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. 2018;12:833-837. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">4. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Palewski<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> M, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Int J Environ Res Public Health. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">2022;19:11357. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">5. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Hilberg F, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Cancer Res<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. 2008;68:4774\u20134782. 6. Yang R, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Invest <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Ophthalmol<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> Vis Sci <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">.2019;60(9):2087. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">7<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Whitcup<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> SM, et al. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">Ophthalmol<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; font-style: italic; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> Sci<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">. 2024. Publication in press. <\/span><u><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: #0563c1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-color: #0563C1; mso-style-textfill-fill-alpha: 100.0%;\"><a href=\"https:\/\/doi.org\/10.1016\/j.xops.2024.100502\">https:\/\/doi.org\/10.1016\/j.xops.2024.100502<\/a><\/span><\/u><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">.<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Calibri; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\"> 8. <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">ClinicalTrials.gov. A clinical trial on safety and <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">efficacy <\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">of CBT-001 in patients with pterygium. Updated March 15, 2024. Accessed March 15, 2024. https:\/\/clinicaltrials.gov\/study\/NCT05456425.<\/span><span style=\"font-size: 9.0pt; font-family: Arial; mso-ascii-font-family: Arial; mso-fareast-font-family: Arial; mso-bidi-font-family: Arial; color: black; mso-color-index: 1; mso-font-kerning: 1.0pt; language: en-US; mso-style-textfill-type: solid; mso-style-textfill-fill-themecolor: text1; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%;\">\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>CBT-001 A potential first-in-class treatment for patients with pterygium CBT-011 is currently in a Phase 3 clinical trial (NCT05456425) as a disease-modifying eyedrop therapy for pterygium. Breakthrough Innovation Our Core Product CBT-001 is a potential first-in-class drug therapy using a multi-kinase inhibitor targeting platelet-derived growth factor receptors (\u201cPDGFRs\u201d), fibroblast growth factor receptors (\u201cFGFRs\u201d), and vascular [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":48,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-771","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CBT-001 - Cloudbreak Pharma, Inc.<\/title>\n<meta name=\"description\" content=\"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We&#039;re working on an eye drop that may provide relief and better quality of life for patients\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cloudbreakpharma.com\/zh\/pipeline\/cbt-001\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CBT-001 - Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We&#039;re working on an eye drop that may provide relief and better quality of life for patients\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cloudbreakpharma.com\/zh\/pipeline\/cbt-001\/\" \/>\n<meta property=\"og:site_name\" content=\"Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T21:15:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"676\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/\",\"name\":\"CBT-001 - Cloudbreak Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Phase-2_trial_graphic-1.png\",\"datePublished\":\"2024-04-03T03:22:38+00:00\",\"dateModified\":\"2026-04-02T21:15:18+00:00\",\"description\":\"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We're working on an eye drop that may provide relief and better quality of life for patients\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Phase-2_trial_graphic-1.png\",\"contentUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Phase-2_trial_graphic-1.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-001\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pipeline\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CBT-001\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"name\":\"Cloudbreak Pharma, Inc.\",\"description\":\"Seeing Life Better Through Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cloudbreakpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\",\"name\":\"Cloudbreak Pharma, Inc.\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"contentUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"width\":824,\"height\":199,\"caption\":\"Cloudbreak Pharma, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CBT-001 - Cloudbreak Pharma, Inc.","description":"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We're working on an eye drop that may provide relief and better quality of life for patients","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cloudbreakpharma.com\/zh\/pipeline\/cbt-001\/","og_locale":"zh_CN","og_type":"article","og_title":"CBT-001 - Cloudbreak Pharma, Inc.","og_description":"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We're working on an eye drop that may provide relief and better quality of life for patients","og_url":"https:\/\/cloudbreakpharma.com\/zh\/pipeline\/cbt-001\/","og_site_name":"Cloudbreak Pharma, Inc.","article_modified_time":"2026-04-02T21:15:18+00:00","og_image":[{"width":676,"height":380,"url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"3 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/","url":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/","name":"CBT-001 - Cloudbreak Pharma, Inc.","isPartOf":{"@id":"https:\/\/cloudbreakpharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/#primaryimage"},"image":{"@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/#primaryimage"},"thumbnailUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png","datePublished":"2024-04-03T03:22:38+00:00","dateModified":"2026-04-02T21:15:18+00:00","description":"Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! We're working on an eye drop that may provide relief and better quality of life for patients","breadcrumb":{"@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/#primaryimage","url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png","contentUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2024\/04\/Phase-2_trial_graphic-1.png"},{"@type":"BreadcrumbList","@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-001\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cloudbreakpharma.com\/"},{"@type":"ListItem","position":2,"name":"Pipeline","item":"https:\/\/cloudbreakpharma.com\/pipeline\/"},{"@type":"ListItem","position":3,"name":"CBT-001"}]},{"@type":"WebSite","@id":"https:\/\/cloudbreakpharma.com\/#website","url":"https:\/\/cloudbreakpharma.com\/","name":"Cloudbreak Pharma, Inc.","description":"\u533b\u836f\u4f7f\u6211\u4eec\u80fd\u66f4\u597d\u7684\u89c6\u89c9\u4eab\u53d7\u751f\u6d3b","publisher":{"@id":"https:\/\/cloudbreakpharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cloudbreakpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Organization","@id":"https:\/\/cloudbreakpharma.com\/#organization","name":"Cloudbreak Pharma, Inc.","url":"https:\/\/cloudbreakpharma.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","contentUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","width":824,"height":199,"caption":"Cloudbreak Pharma, Inc."},"image":{"@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/pages\/771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/comments?post=771"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/pages\/771\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/pages\/48"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh\/wp-json\/wp\/v2\/media?parent=771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}